Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 9553
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473978(US10858344, Example 88)
Affinity DataIC50: 800nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473979(US10858344, Example 89)
Affinity DataIC50: 800nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473988(US10858344, Example 99)
Affinity DataIC50: 1.25E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473973(US10858344, Example 81)
Affinity DataIC50: 1.30E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473975(US10858344, Example 83)
Affinity DataIC50: 2.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473977(US10858344, Example 87)
Affinity DataIC50: 2.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473980(US10858344, Example 90)
Affinity DataIC50: 2.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473976(US10858344, Example 84)
Affinity DataIC50: 2.50E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473974(US10858344, Example 82)
Affinity DataIC50: 3.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473987(US10858344, Example 98)
Affinity DataIC50: 3.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473983(US10858344, Example 93)
Affinity DataIC50: 3.75E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473986(US10858344, Example 96)
Affinity DataIC50: 4.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473982(US10858344, Example 92)
Affinity DataIC50: 6.25E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473989(US10858344, Example 100)
Affinity DataIC50: 1.40E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473990(US10858344, Example 101)
Affinity DataIC50: 2.00E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473985(US10858344, Example 95)
Affinity DataIC50: 2.50E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473991(US10858344, Example 102)
Affinity DataIC50: 2.50E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473984(US10858344, Example 94)
Affinity DataIC50: 1.50E+5nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473981(US10858344, Example 91)
Affinity DataIC50: 1.50E+5nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Human)
CV6 Therapeutics (NI)

US Patent
LigandPNGBDBM473992(US10858344, Example 106)
Affinity DataIC50: 1.50E+5nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent